Anna Hernández‐Aguilera

2.1k total citations
69 papers, 1.1k citations indexed

About

Anna Hernández‐Aguilera is a scholar working on Clinical Biochemistry, Molecular Biology and Epidemiology. According to data from OpenAlex, Anna Hernández‐Aguilera has authored 69 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Clinical Biochemistry, 18 papers in Molecular Biology and 18 papers in Epidemiology. Recurrent topics in Anna Hernández‐Aguilera's work include Paraoxonase enzyme and polymorphisms (19 papers), Diet and metabolism studies (15 papers) and Liver Disease Diagnosis and Treatment (14 papers). Anna Hernández‐Aguilera is often cited by papers focused on Paraoxonase enzyme and polymorphisms (19 papers), Diet and metabolism studies (15 papers) and Liver Disease Diagnosis and Treatment (14 papers). Anna Hernández‐Aguilera collaborates with scholars based in Spain, Australia and Denmark. Anna Hernández‐Aguilera's co-authors include Jorge Joven, Jordi Camps, Fedra Luciano‐Mateo, Javier A. Menéndez, Salvador Fernández‐Arroyo, Esther Rodríguez‐Gallego, Noemí Cabré, Marta Riera-Borrull, Anabel García‐Heredia and Gerard Baiges‐Gayà and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Anna Hernández‐Aguilera

66 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Hernández‐Aguilera Spain 20 362 264 203 185 172 69 1.1k
Yu Ah Hong South Korea 18 415 1.1× 215 0.8× 232 1.1× 98 0.5× 218 1.3× 83 1.4k
Jun Watanabe Japan 19 269 0.7× 182 0.7× 248 1.2× 152 0.8× 406 2.4× 143 1.3k
Hong Yu China 20 326 0.9× 189 0.7× 124 0.6× 74 0.4× 235 1.4× 67 1.1k
Andy K. H. Lim Australia 12 392 1.1× 180 0.7× 107 0.5× 236 1.3× 233 1.4× 44 1.5k
Farsad Afshinnia United States 24 501 1.4× 223 0.8× 272 1.3× 81 0.4× 264 1.5× 47 1.7k
Mevlüt Başkol Türkiye 17 263 0.7× 291 1.1× 99 0.5× 171 0.9× 143 0.8× 50 1.0k
Nataša Bogavac‐Stanojević Serbia 18 202 0.6× 233 0.9× 132 0.7× 143 0.8× 280 1.6× 107 1.3k
Éva Szabó Hungary 16 261 0.7× 183 0.7× 205 1.0× 90 0.5× 111 0.6× 49 1.3k
Dorota Formanowicz Poland 17 289 0.8× 121 0.5× 146 0.7× 57 0.3× 132 0.8× 87 1.1k
Khalid Siddiqui Saudi Arabia 20 332 0.9× 180 0.7× 135 0.7× 56 0.3× 115 0.7× 67 1.3k

Countries citing papers authored by Anna Hernández‐Aguilera

Since Specialization
Citations

This map shows the geographic impact of Anna Hernández‐Aguilera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Hernández‐Aguilera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Hernández‐Aguilera more than expected).

Fields of papers citing papers by Anna Hernández‐Aguilera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Hernández‐Aguilera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Hernández‐Aguilera. The network helps show where Anna Hernández‐Aguilera may publish in the future.

Co-authorship network of co-authors of Anna Hernández‐Aguilera

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Hernández‐Aguilera. A scholar is included among the top collaborators of Anna Hernández‐Aguilera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Hernández‐Aguilera. Anna Hernández‐Aguilera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iftimie, Simona, Ana F. López‐Azcona, Helena Castañé, et al.. (2023). Retrospective Analysis of Vaccination Status and Predominant Viral Variants in Patients Hospitalized with COVID-19 in Reus, Spain. Viruses. 15(4). 886–886. 1 indexed citations
2.
Castañé, Helena, Anna Hernández‐Aguilera, Salvador Fernández‐Arroyo, et al.. (2023). Metabolic adaptations in severe obesity: Insights from circulating oxylipins before and after weight loss. Clinical Nutrition. 43(1). 246–258. 10 indexed citations
3.
4.
Iftimie, Simona, Anna Hernández‐Aguilera, Ana F. López‐Azcona, et al.. (2022). Measurement of Plasma Galectin-3 Concentrations in Patients with Catheter Infections: A Post Hoc Retrospective Cohort Study. Diagnostics. 12(10). 2418–2418.
5.
Gumà, Josep, Francesc Riu, Anna Hernández‐Aguilera, et al.. (2022). Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA Samples. Cancers. 14(23). 5859–5859.
6.
7.
Castañé, Helena, Gerard Baiges‐Gayà, Anna Hernández‐Aguilera, et al.. (2021). Coupling Machine Learning and Lipidomics as a Tool to Investigate Metabolic Dysfunction-Associated Fatty Liver Disease. A General Overview. Biomolecules. 11(3). 473–473. 18 indexed citations
8.
Camps, Jordi, Helena Castañé, Elisabet Rodríguez‐Tomàs, et al.. (2021). On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 Update. Biomolecules. 11(7). 971–971. 25 indexed citations
9.
Rodríguez‐Tomàs, Elisabet, Simona Iftimie, Helena Castañé, et al.. (2021). Clinical Performance of Paraoxonase-1-Related Variables and Novel Markers of Inflammation in Coronavirus Disease-19. A Machine Learning Approach. Antioxidants. 10(6). 991–991. 14 indexed citations
10.
Baiges‐Gayà, Gerard, Salvador Fernández‐Arroyo, Fedra Luciano‐Mateo, et al.. (2020). Hepatic metabolic adaptation and adipose tissue expansion are altered in mice with steatohepatitis induced by high-fat high sucrose diet. The Journal of Nutritional Biochemistry. 89. 108559–108559. 19 indexed citations
11.
Rodríguez‐Tomàs, Elisabet, M. Murcia, Meritxell Arenas, et al.. (2019). Serum Paraoxonase-1-Related Variables and Lipoprotein Profile in Patients with Lung or Head and Neck Cancer: Effect of Radiotherapy. Antioxidants. 8(7). 213–213. 17 indexed citations
12.
Fernández‐Arroyo, Salvador, Anna Hernández‐Aguilera, Marijke A. de Vries, et al.. (2019). Effect of Vitamin D3 on the Postprandial Lipid Profile in Obese Patients: A Non-Targeted Lipidomics Study. Nutrients. 11(5). 1194–1194. 21 indexed citations
13.
Luciano‐Mateo, Fedra, Noemí Cabré, Salvador Fernández‐Arroyo, et al.. (2019). Chemokine (C-C motif) ligand 2 gene ablation protects low-density lipoprotein and paraoxonase-1 double deficient mice from liver injury, oxidative stress and inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(6). 1555–1566. 10 indexed citations
14.
Hernández‐Aguilera, Anna, Salvador Fernández‐Arroyo, Noemí Cabré, et al.. (2018). Plasma Energy-Balance Metabolites Discriminate Asymptomatic Patients with Peripheral Artery Disease. Mediators of Inflammation. 2018. 1–12. 9 indexed citations
15.
Luciano‐Mateo, Fedra, Noemí Cabré, Martí Nadal, et al.. (2018). Serum concentrations of trace elements and their relationships with paraoxonase-1 in morbidly obese women. Journal of Trace Elements in Medicine and Biology. 48. 8–15. 14 indexed citations
16.
Fort-Gallifa, Isabel, Anna Hernández‐Aguilera, Anabel García‐Heredia, et al.. (2017). Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation. International Journal of Molecular Sciences. 18(5). 973–973. 35 indexed citations
17.
Riera-Borrull, Marta, Anabel García‐Heredia, Salvador Fernández‐Arroyo, et al.. (2017). Metformin Potentiates the Benefits of Dietary Restraint: A Metabolomic Study. International Journal of Molecular Sciences. 18(11). 2263–2263. 18 indexed citations
18.
Luciano‐Mateo, Fedra, Anna Hernández‐Aguilera, Noemí Cabré, et al.. (2017). Nutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users. Nutrients. 9(2). 121–121. 33 indexed citations
19.
Hernández‐Aguilera, Anna, Esther Rodríguez‐Gallego, María Guirro, et al.. (2015). Immunohistochemical Analysis of Paraoxonases and Chemokines in Arteries of Patients with Peripheral Artery Disease. International Journal of Molecular Sciences. 16(5). 11323–11338. 23 indexed citations
20.
Rodríguez‐Gallego, Esther, María Guirro, Marta Riera-Borrull, et al.. (2014). Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease. International Journal of Obesity. 39(2). 279–287. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu Ah Hong Breakdown of academic impact, for papers by Jun Watanabe Breakdown of academic impact, for papers by Hong Yu Breakdown of academic impact, for papers by Andy K. H. Lim Breakdown of academic impact, for papers by Farsad Afshinnia Breakdown of academic impact, for papers by Mevlüt Başkol Breakdown of academic impact, for papers by Nataša Bogavac‐Stanojević Breakdown of academic impact, for papers by Éva Szabó Breakdown of academic impact, for papers by Dorota Formanowicz Breakdown of academic impact, for papers by Khalid Siddiqui
Rankless by CCL
2026